ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026
Preoperative prediction of Ki-67 expression and prognosis in breast cancer based on contrast-enhanced cone-beam breast CT: a two-centre study.
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThis study aimed to develop and validate preoperative contrast-enhanced cone-beam breast CT (CE-CBBCT)-based radiomics, deep learning, and combined models for predicting Ki-67 expression status and to preliminarily explore their prognostic value, with the goal of informing preoperative treatment decisions.
methodsThis two-centre study enrolled 636 breast cancer patients, divided into training (n = 310), internal validation (n = 77), external test (n = 78), and prognostic (n = 171) cohorts. Two Ki-67 cut-offs (14% and 30%) were applied. Radiomics models were constructed using five machine learning classifiers, and deep learning models using four three-dimensional architectures (ResNet50, ResNet101, DenseNet121, and ShuffleNet). The best-performing models from each category were integrated with the clinical model using logistic regression to establish combined models. Prognostic value was evaluated using disease-free survival (DFS) in the prognostic cohort.
resultsAmong the radiomics models, those based on ExtraTrees and eXtreme Gradient Boosting performed best for the 14% and 30% cut-offs, respectively, with areas under the receiver operating characteristic curves (AUCs) of 0.885 and 0.831 in the external test cohort. Among the deep learning architectures, ShuffleNet performed best, with corresponding AUCs of 0.630 and 0.825. Combined models achieved the highest AUCs of 0.895 and 0.869 for the 14% and 30% cut-offs, respectively, in the external test cohort. However, they did not significantly outperform the corresponding radiomics models. In survival analysis, the radiomics score for predicting Ki-67 ≥ 30% was an independent prognostic factor for DFS (hazard ratio: 1.661; 95% confidence interval: 1.142-2.417; P = 0.008).
conclusionsCE-CBBCT-based radiomics models demonstrated utility as non-invasive tools for the preoperative prediction of high Ki-67 expression defined at both the 14% and 30% cut-offs. The prognostic value of the radiomics score for predicting Ki-67 ≥ 30% was preliminarily demonstrated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.